FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313281254> ?p ?o ?g. }

• W4313281254 endingPage "17" @default.
• W4313281254 startingPage "1" @default.
• W4313281254 abstract "The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have recently undergone testing for their ability to reduce residual cardiovascular (CV) risk among statin-treated subjects. The outcome trials have yielded highly inconsistent results, perhaps attributable to variations in dosage, formulation, and composition. In particular, CV trials using icosapent ethyl (IPE), a highly purified ethyl ester of EPA, reproducibly reduced CV events and progression of atherosclerosis compared with mixed EPA/DHA treatments. This review summarizes the mechanistic evidence for differences among n3-FAs on the development and manifestations of atherothrombotic disease.Large randomized clinical trials with n3-FAs have produced discordant outcomes despite similar patient profiles, doses, and triglyceride (TG)-lowering effects. A large, randomized trial with IPE, a prescription EPA only formulation, showed robust reduction in CV events in statin treated patients in a manner proportional to achieved blood EPA concentrations. Multiple trials using mixed EPA/DHA formulations have not shown such benefits, despite similar TG lowering. These inconsistencies have inspired investigations into mechanistic differences among n3-FAs, as EPA and DHA have distinct membrane interactions, metabolic products, effects on cholesterol efflux, antioxidant properties, and tissue distribution. EPA maintains normal membrane cholesterol distribution, enhances endothelial function, and in combination with statins improves features implicated in plaque stability and reduces lipid content of plaques. Insights into reductions in residual CV risk have emerged from clinical trials using different formulations of n3-FAs. Among high-risk patients on contemporary care, mixed n3-FA formulations showed no reduction in CV events. The distinct benefits of IPE in multiple trials may arise from pleiotropic actions that correlate with on-treatment EPA levels beyond TG-lowering. These effects include altered platelet function, inflammation, cholesterol distribution, and endothelial dysfunction. Elucidating such mechanisms of vascular protection for EPA may lead to new interventions for atherosclerosis, a disease that continues to expand worldwide." @default.
• W4313281254 created "2023-01-06" @default.
• W4313281254 creator A5003822075 @default.
• W4313281254 creator A5010571732 @default.
• W4313281254 creator A5014390206 @default.
• W4313281254 creator A5020326679 @default.
• W4313281254 creator A5043201732 @default.
• W4313281254 date "2022-12-29" @default.
• W4313281254 modified "2023-10-10" @default.
• W4313281254 title "Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues" @default.
• W4313281254 cites W147553750 @default.
• W4313281254 cites W1546456778 @default.
• W4313281254 cites W1672804368 @default.
• W4313281254 cites W1729853508 @default.
• W4313281254 cites W1853875009 @default.
• W4313281254 cites W1856460279 @default.
• W4313281254 cites W1925096404 @default.
• W4313281254 cites W1961127914 @default.
• W4313281254 cites W1966788643 @default.
• W4313281254 cites W1972483153 @default.
• W4313281254 cites W1977070020 @default.
• W4313281254 cites W1992587140 @default.
• W4313281254 cites W1997036377 @default.
• W4313281254 cites W1998520778 @default.
• W4313281254 cites W2006574739 @default.
• W4313281254 cites W2006598457 @default.
• W4313281254 cites W2015979373 @default.
• W4313281254 cites W2019948816 @default.
• W4313281254 cites W2026578933 @default.
• W4313281254 cites W2031550562 @default.
• W4313281254 cites W2032824150 @default.
• W4313281254 cites W2033896075 @default.
• W4313281254 cites W203962887 @default.
• W4313281254 cites W2041298812 @default.
• W4313281254 cites W2043060401 @default.
• W4313281254 cites W2044165621 @default.
• W4313281254 cites W2047319374 @default.
• W4313281254 cites W2048776656 @default.
• W4313281254 cites W2064358352 @default.
• W4313281254 cites W2064923580 @default.
• W4313281254 cites W2069157558 @default.
• W4313281254 cites W2076375837 @default.
• W4313281254 cites W2078218315 @default.
• W4313281254 cites W2086075261 @default.
• W4313281254 cites W2087020389 @default.
• W4313281254 cites W2088359261 @default.
• W4313281254 cites W2091743718 @default.
• W4313281254 cites W2092145002 @default.
• W4313281254 cites W2093135493 @default.
• W4313281254 cites W2093914979 @default.
• W4313281254 cites W2095512766 @default.
• W4313281254 cites W2095768296 @default.
• W4313281254 cites W2101841000 @default.
• W4313281254 cites W2103961074 @default.
• W4313281254 cites W2104063220 @default.
• W4313281254 cites W2104285446 @default.
• W4313281254 cites W2107665972 @default.
• W4313281254 cites W2109730331 @default.
• W4313281254 cites W2112710165 @default.
• W4313281254 cites W2113551399 @default.
• W4313281254 cites W2113638285 @default.
• W4313281254 cites W2117187480 @default.
• W4313281254 cites W2120469313 @default.
• W4313281254 cites W2124920528 @default.
• W4313281254 cites W2125843274 @default.
• W4313281254 cites W2127427274 @default.
• W4313281254 cites W2131094572 @default.
• W4313281254 cites W2131385716 @default.
• W4313281254 cites W2132674183 @default.
• W4313281254 cites W2137188853 @default.
• W4313281254 cites W2137983259 @default.
• W4313281254 cites W2138825852 @default.
• W4313281254 cites W2142347023 @default.
• W4313281254 cites W2142678310 @default.
• W4313281254 cites W2144340361 @default.
• W4313281254 cites W2144516660 @default.
• W4313281254 cites W2151839802 @default.
• W4313281254 cites W2153889396 @default.
• W4313281254 cites W2156490538 @default.
• W4313281254 cites W2163411964 @default.
• W4313281254 cites W2164280695 @default.
• W4313281254 cites W2164324917 @default.
• W4313281254 cites W2165605025 @default.
• W4313281254 cites W2168175864 @default.
• W4313281254 cites W2169760772 @default.
• W4313281254 cites W2170009139 @default.
• W4313281254 cites W2171584145 @default.
• W4313281254 cites W2275204317 @default.
• W4313281254 cites W2286999219 @default.
• W4313281254 cites W2290053204 @default.
• W4313281254 cites W2406165148 @default.
• W4313281254 cites W2463964759 @default.
• W4313281254 cites W2510102221 @default.
• W4313281254 cites W2523453502 @default.
• W4313281254 cites W2527894800 @default.
• W4313281254 cites W2554388788 @default.
• W4313281254 cites W2565061828 @default.
• W4313281254 cites W2584235667 @default.

• next